CARM1 and ovarian carcinoma: To test whether IRE1α inhibition is synergistic with immune checkpoint blockade, we utilized a syngeneic immune-competent mouse model using UPK10 mouse ovarian cancer cell line23 that expresses CARM1 at a comparable level as those observed in A1847 cells (Fig. 7a).